Back
Theralase Technologies, Inc. 10K Form
Sell
14
TLT.V
Theralase Technologies, Inc.
Last Price:
$0.15
Seasonality Move:
-11.32%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TLT.V News And Ratings
See the #1 stock for the next 7 days that we like better than TLT.V
TLT.V Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-702.3K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 36.47 |
Profitability
| EPS (TTM): | -0.01740 |
|---|---|
| Net Income (TTM): | $-4.4M |
| Gross Margin: | $305.2K |
| Return on Equity: | -283.94% |
| Return on Assets: | -140.89% |
Theralase Technologies, Inc. Earnings Forecast
Key Theralase Technologies, Inc. Financial Ratios
-
The Gross Profit Margin over the past 22 years for TLT.V is 29.53%.
-
The Selling, General & Administrative Expenses for TLT.V have been equal to 202.12% of Gross Profit Margin.
-
The Research & Development expenses have been 246.24% of Revenue.
-
The Net Earning history of TLT.V is -411.85% of Total Revenues.
-
Per Share Earnings over the last 24 years have been positive in 13 years.
Theralase Technologies, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSXV |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | TLT.V |
| Website: | theralase.com |
Debt
| Debt-to-Equity Ratio: | 0.29 |
|---|---|
| Current Ratio: | 0.83 |
| Quick Ratio: | 0.05 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TLT.V Technical Analysis vs Fundamental Analysis
Sell
14
Theralase Technologies, Inc. (TLT.V)
is a Sell
Is Theralase Technologies, Inc. a Buy or a Sell?
-
Theralase Technologies, Inc. stock is rated a SellThe current Theralase Technologies, Inc. [TLT.V] share price is $0.15. The Score for TLT.V is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.